| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/25/1992 | CA1306746C Cyclic amino-thioacetal amides, a process for the preparation thereofand pharmaceutical compositions containing them |
| 08/25/1992 | CA1306683C Methods and compositions for preventing ulcers |
| 08/23/1992 | CA2061629A1 5-(substituted amino)-1,2,4- triazolo¬1,5-a|pyrimidine derivatives |
| 08/21/1992 | CA2060965A1 Piperidine derivatives |
| 08/20/1992 | WO1992013855A1 (2-imidazolin-2-ylamino) tetrahydroquinolaxines and methods for using same |
| 08/20/1992 | WO1992013844A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| 08/20/1992 | WO1992013515A1 Non-antibacterial tetracycline compositions possessing antiplaque properties |
| 08/20/1992 | CA2365269A1 Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines |
| 08/19/1992 | EP0499313A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 08/19/1992 | EP0233284B1 Pharmacological compounds |
| 08/19/1992 | CA2061311A1 New phenylethanolamino- and phenylethanolaminomethyltetralines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| 08/18/1992 | US5140038 Thromboxane A2 antagonists |
| 08/18/1992 | US5140023 Azatetracycle compounds |
| 08/12/1992 | EP0498723A1 Nitrogen containing bicycle compounds, method for their preparation, their use as pharmaceutical and compositions containing them |
| 08/12/1992 | EP0498722A1 Bicyclic nitrogen compounds, their preparation, intermediates obtained, their use as pharmaceuticals and pharmaceutical compositions containing them |
| 08/12/1992 | EP0498721A1 N-substituted quinoline derivatives, process for their preparation, intermediates obtained, their use as pharmaceuticals and pharmaceutical compositions containing them |
| 08/12/1992 | EP0498718A1 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydro-pyridine-derivatives as free radical scavengers |
| 08/12/1992 | EP0498665A1 Hydroxamic acids derivatives, process for their preparation and use thereof |
| 08/12/1992 | EP0498590A1 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes |
| 08/12/1992 | EP0498466A1 Indazole-3-carboxamide and -3-carboxylic acid derivatives |
| 08/12/1992 | EP0498069A2 New use of peptide derivative |
| 08/12/1992 | EP0201575B1 New picoline derivatives, preparation process thereof, utilization thereof and drugs containing them |
| 08/12/1992 | CN1063507A Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
| 08/12/1992 | CA2060949A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy |
| 08/11/1992 | US5138060 Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
| 08/11/1992 | US5138039 Diagnosis, therapy |
| 08/11/1992 | US5137901 For binding 5-HT 1 receptors; treating central nervous system disorders |
| 08/11/1992 | CA1306255C Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives |
| 08/08/1992 | WO1992013831A1 Hydroxamic acid derivatives, process for their preparation and use thereof |
| 08/08/1992 | CA2100661A1 Hydroxamic acid derivatives, process for their preparation and use thereof |
| 08/08/1992 | CA2060843A1 N-substituted derivatives of quinoleine, process for their preparation, new intermediates obtaines, their application as drugs and pharmaceutical compositions containing them |
| 08/08/1992 | CA2060771A1 Nitrogenated bicyclic derivatives substitutes by a benzyl radical, process for their preparation, novel intermediates thus obtaines, their applications as drugs, and pharmaceutical compositions containing them |
| 08/08/1992 | CA2060750A1 Bicyclic nitrogenated derivatives, process for their preparation, novel intermediates thus obtaines, their applications as drugs, and phamarceutical compositions containing them |
| 08/06/1992 | WO1992013095A1 Methods for treating tumor necrosis factor mediated diseases |
| 08/06/1992 | WO1992012960A2 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
| 08/06/1992 | WO1992012716A1 Pharmaceutical composition containing granisetron and dexamethasone |
| 08/05/1992 | EP0497724A1 An agent for disintegrating gallstones |
| 08/05/1992 | EP0497258A2 Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer |
| 08/05/1992 | EP0497001A2 Oxidized-type glutathione alkyl ester |
| 08/05/1992 | EP0261185B1 7-oxoprostacycline derivatives and process for their manufacture |
| 08/01/1992 | WO1992013545A1 Endothelin converting enzyme inhibitors |
| 08/01/1992 | CA2100171A1 Endothelin converting enzyme inhibitors |
| 07/30/1992 | WO1992012969A1 Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion |
| 07/30/1992 | CA2099117A1 Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion |
| 07/30/1992 | CA2060138A1 New use of the adenosine antagonist |
| 07/29/1992 | EP0496452A1 Novel endothelin receptor antagonists isolated from microbispora |
| 07/29/1992 | EP0496437A2 Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of omeprazole |
| 07/29/1992 | EP0435996A4 Modified transforming growth factor -g(a) oligopeptides and pharmaceutical compositions thereof |
| 07/29/1992 | EP0313643B1 Methods and compositions for preventing ulcers |
| 07/28/1992 | US5134149 Serotonin antagonist |
| 07/28/1992 | US5134142 Pyrazole derivatives, and pharmaceutical composition comprising the same |
| 07/27/1992 | CA2059977A1 Agent for disintegrating gallstones |
| 07/25/1992 | CA2059380A1 Endothelin receptor antagonists isolated from microbispora |
| 07/23/1992 | WO1992012721A1 Amylase-electrolyte oral rehydration method and apparatus |
| 07/23/1992 | WO1992008697A3 9-HALOGEN-11β-HYDROXY PROSTAGLANDIN DERIVATIVE, PROCESS FOR PRODUCING IT AND ITS USE AS A MEDICAMENT |
| 07/23/1992 | CA2100252A1 Amylase-electrolyte oral rehydration method and apparatus |
| 07/22/1992 | EP0495473A1 New diazepines substituted in position 6, process for their production and their use as drugs |
| 07/22/1992 | EP0495105A1 Inhibitor of absorption of digestion product of food and drink |
| 07/22/1992 | EP0494995A1 Cosmetic method of inhibiting the formation of a scar |
| 07/22/1992 | EP0494904A1 Device for oral administration of an active principle for preventive treatment of caries in babies. |
| 07/21/1992 | US5132292 Treatment of viral hepatitis |
| 07/21/1992 | CA1305424C Use of 15-deoxyspergualine as a pharmaceutical |
| 07/17/1992 | CA2059353A1 Diazepines substituted in the 6-position, processes for their preparation and their preparation and their use as pharmaceutical compositions |
| 07/15/1992 | EP0494825A1 Synthetic peptides, derived from HBc antigen of hepatitis B virus |
| 07/15/1992 | EP0494512A2 Composition and method for preventing fluorosis |
| 07/14/1992 | US5130487 Aminopropanol derivatives, process for their preparation and pharmaceutical compositions comprising the same |
| 07/14/1992 | US5130485 N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents |
| 07/14/1992 | US5130474 For treatment of gastrointestinal disorders such as colitis, pancreatitis, antispastic agents and biliary diskinesia |
| 07/14/1992 | US5130339 Phenylethanolaminomethyltetralins and pharmaceutical use |
| 07/14/1992 | US5130323 Anticoagulants, thromboxane A2 antagonist and enzyme inhibitor for treatment of nephtitis and asthma |
| 07/14/1992 | US5130245 Insert containing dna coding system; treatment of diseases causes by superoxide radicals |
| 07/09/1992 | WO1992011368A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 07/09/1992 | WO1992011287A1 Vasopressin and vasotocin derivates |
| 07/08/1992 | EP0494119A1 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis B |
| 07/08/1992 | EP0493380A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs. |
| 07/08/1992 | CN1062526A Alkylaminoalkylamine and etherifying compounds and process for preparing same and intermediates and pharmaceuticals containing same |
| 07/08/1992 | CN1062525A Phenylalkylamino compounds and process for preparing same and pharmaceuticals containing same |
| 07/07/1992 | US5128477 Famotidine |
| 07/07/1992 | US5128367 Osteoporosis |
| 07/04/1992 | WO1992012152A1 Process and intermediates for preparing azabicyclo[2.2.2]octan-3-imines |
| 07/04/1992 | WO1992011852A1 Use of 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis b |
| 07/04/1992 | CA2254613A1 1,3-oxathiolane nucleoside analogues in the treatment of hepatitis b |
| 07/01/1992 | EP0493362A2 Compositions and kits for the treatment of oral diseases |
| 07/01/1992 | EP0493031A1 Dihydrobenzofuran carboxamides and process for their preparation |
| 07/01/1992 | EP0492247A1 Effervescent H2 blocker formulation |
| 07/01/1992 | EP0491770A1 Substituted urea compounds and their preparation and use |
| 07/01/1992 | EP0423318A4 Therapeutic cholesterol gallstone dissolution method |
| 07/01/1992 | EP0179858B1 Antacid composition |
| 07/01/1992 | CN1062293A Compositions containing psyllium |
| 07/01/1992 | CN1017242B New quianzoline derivatives and process for their production |
| 06/30/1992 | US5126365 Bicyclic derivatives |
| 06/29/1992 | WO1992012140A1 Peptides ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2098702A1 Peptide ketoamides, ketoacids, and ketoesters |
| 06/25/1992 | WO1992010755A1 Proteins with changed epitopes and methods for the production thereof |
| 06/25/1992 | WO1992010289A1 Chlorinated alumina-based catalyst and its use in normal c4-c6 paraffins |
| 06/25/1992 | WO1992009586A1 Active oxygen inhibitor |
| 06/25/1992 | DE4042008A1 Vasopressin-derivate Vasopressin derivatives |
| 06/24/1992 | EP0491263A1 Phenylalkylaminoalkyl compounds; process for their preparation and pharmaceutical compositions containing same |
| 06/24/1992 | EP0491243A1 Alkylaminoalkylamino and -ether compounds as well as processes and intermediates for their preparation, and medicaments containing these compounds |
| 06/24/1992 | EP0491077A1 A composition used as a therapeutic agent against chronic viral hepatic diseases |